YDES
YD Bio Limited Ordinary Shares NASDAQ Listed Aug 29, 2025$1.96
-15.15%
vs $2.31
Mkt Cap $138.8M
52w Low $1.70
1.1% of range
52w High $25.00
50d MA $4.00
200d MA $9.74
P/E (TTM)
—
EV/EBITDA
—
P/B
1.2x
Debt/Equity
0.0x
ROE
—
P/FCF
-2.0x
RSI (14)
33.70
ATR (14)
$0.43
Beta
0.22
50d MA
$4.00
200d MA
$9.74
Avg Volume
46.3K
Breeze Holdings Acquisition Corp. operates as a clinical-stage biopharmaceutical company focuses on cancer prevention medical diagnostics and the development of exosome-based therapeutics with the potential to transform the treatment of a diseases with unmet medical need. The company is based in Taipei, Taiwan.
No. 3, Xingnan St. · Taipei, TX 115001 · TW
Data updated apr 24, 2026 11:46am
· Source: financialmodelingprep.com